ID

27407

Descripción

Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977

Palabras clave

  1. 13/11/17 13/11/17 -
  2. 13/11/17 13/11/17 -
  3. 26/11/17 26/11/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

13 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

TNM Staging GSK study Prostatic neoplasms NCT00883909

TNM Staging GSK study Prostatic neoplasms NCT00883909

Administrative data
Descripción

Administrative data

Session number
Descripción

Session number

Tipo de datos

integer

Subject number
Descripción

Subject number

Tipo de datos

text

TNM Staging History
Descripción

TNM Staging History

Date of Stage Determination
Descripción

Date of Stage Determination

Tipo de datos

date

TNM Stage: Primary Tumor
Descripción

Staging of Prostate Cancer (TNM) (1992)

Tipo de datos

text

TNM Stage: Regional Lymph Nodes
Descripción

Staging of Prostate Cancer (TNM) (1992)

Tipo de datos

text

TNM Stage: Distant Metastases
Descripción

Staging of Prostate Cancer (TNM) (1992)

Tipo de datos

text

Similar models

TNM Staging GSK study Prostatic neoplasms NCT00883909

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
Session number
Item
Session number
integer
Subject number
Item
Subject number
text
Item Group
TNM Staging History
Date of Stage Determination
Item
Date of Stage Determination
date
Item
TNM Stage: Primary Tumor
text
Code List
TNM Stage: Primary Tumor
CL Item
Nonpalpable Cancer (T1)
CL Item
Five percent or less of TURP tissue (or resected tissue) (T1a)
CL Item
More than 5% of TURP tissue (or resected tissue) (T1b)
CL Item
Nonpalpable, nonvisible cancer detected by biopsy (elevated PSA) (T1c)
CL Item
Palpable or Visible Cancer Confined Within the Capsule (T2)
CL Item
Involves 50% or less of one lobe (T2a)
CL Item
Involves more than 50% of one lobe (T2b)
CL Item
Involves both lobes (T2c)
CL Item
Local Extracapsular Extension (T3)
CL Item
T3a Unilateral extracapsular extension (T3a)
CL Item
T3b Bilateral extracapsular extension (T3b)
CL Item
Seminal vesicle invasion (T3c)
CL Item
Invasion of Adjacent Organs and Tissues (T4)
CL Item
T4a Invasion of bladder, neck, rectum, or external sphincter (T4a)
CL Item
Invasion of levator muscle or pelvic wall (T4b)
Item
TNM Stage: Regional Lymph Nodes
text
Code List
TNM Stage: Regional Lymph Nodes
CL Item
Nodal status unknown (NX)
CL Item
No lymph node involvement (N0)
CL Item
Single regional lymph node, 2cm or less in greatest dimension (N1)
CL Item
Single regional lymph node, 2 to 5cm or multiple lymph nodes 5cm or less (N2)
CL Item
Single regional lymph node, more than 5cm (N3)
Item
TNM Stage: Distant Metastases
text
Code List
TNM Stage: Distant Metastases
CL Item
Status unknown (MX)
CL Item
No distant metastases (M0)
CL Item
Nonregional lymph nodes (M1a)
CL Item
Bone (M1b)
CL Item
Other sites (M1c)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial